IP News CJEU Advocate General in Halozyme C-456/24: An Excipient Cannot Be Treated as an Active Ingredient for SPC Purposes
The Court of Justice of the European Union's Advocate General has issued an opinion in Halozyme, Case C-456/24, concludi...
2026.05.19
IP News